Ledipasvir-sofosbuvir plus ribavirin in advanced HCV does well

Combination treatment with ledipasvir, sofosbuvir, and ribavirin for chronic hepatitis C virus infection led to sustained viral response (SVR) rates of 86%-89% among nontransplanted patients and...